Anaes · TIVA & target-controlled infusion
TIVA and target-controlled infusion: the compartment model
Also known as TIVA compartment modelling · Target-controlled infusion · TCI pharmacokinetics · Marsh model · Schnider model · Eleveld model
Total intravenous anaesthesia by target-controlled infusion delivers a drug to a predicted plasma or effect-site concentration computed from a compartment pharmacokinetic model. Understanding the three-compartment mamillary model, context-sensitive half-time, the named propofol models (Marsh, Schnider, Eleveld) and effect-site targeting is what separates safe TIVA practice from blind infusion.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- A TCI pump is only as accurate as its model; the displayed concentration is a prediction, not a measurement — confirm depth with a processed-EEG monitor, especially when physiology distorts the model.
- Deep hypothermia and cardiopulmonary bypass markedly reduce the predictive accuracy of standard propofol models — do not trust the displayed target during cardiac cooling and rewarming.
- Context-sensitive half-time lengthens with infusion duration; long remifentanil or propofol infusions do not wear off promptly simply because the pump is stopped.
- Mixing models (a Marsh propofol target with a Schnider effect-site, or an adult model in a child) produces unpredictable concentrations — use the matched, weight- and age-appropriate model.
- The elderly, frail and haemodynamically compromised patient needs a lower target and titration; a standard young-adult target causes hypotension.
- TCI failure (disconnection, empty syringe, occluded line) delivers no drug and lightens anaesthesia silently — monitor depth and the infusion line.
Meet the patient
A 72-year-old man presents for elective cardiac surgery requiring cardiopulmonary bypass and deep hypothermic circulatory arrest. You plan a propofol-remifentanil TIVA using the Eleveld model. As cooling progresses, the processed-EEG trace shows profound cortical suppression while the stress response activates, but you cannot trust the displayed predicted concentration — because deep hypothermia markedly reduces the model's predictive accuracy. The question is not what target to set, but whether to believe the model at all.[4]
The three questions this topic answers are the three every TIVA pharmacokinetics stem turns on: how does the model predict the concentration? (the compartment model), how long does recovery take after the pump stops? (context-sensitive half-time), and when does the model lie? (the limits of prediction).[7][2]
References8ShowHide
- [1]Ye J, et al. A Prospective Study of Marsh PK-PD Model and Schnider PK-PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery Pharmacol Res Perspect, 2026.PMID 42286797
- [2]Introna M, et al. Target concentrations of propofol predicted by four different pharmacokinetic/pharmacodynamic models to induce loss of consciousness in neurosurgical patients J Anesth Analg Crit Care, 2026.PMID 42231496
- [3]Lybbert C, et al. Correction: Clinical validation of an adapted Eleveld Model for high‑dose propofol treatments for depression J Clin Monit Comput, 2026.PMID 42360600
- [4]Bartošová T, Šíma M, Prskavec T, et al. Deep hypothermia reduces the predictive accuracy of the Eleveld propofol model: Population pharmacokinetic modelling in cardiac surgery Biomed Pharmacother, 2026.PMID 42140058
- [5]Somnuke P, et al. Effect of desflurane versus propofol on perioperative neurocognitive disorders in older adults undergoing major urological surgery: a randomized trial BMC Geriatr, 2026.PMID 42321629
- [6]Ramesh S, et al. Integrated Advanced Monitoring and Target-Controlled Infusion Anesthesia in a Child With Arthrogryposis Multiplex Congenita Cureus, 2026.PMID 42359210
- [7]Sahinovic MM, et al. Clinical Pharmacokinetics and Pharmacodynamics of Propofol Clin Pharmacokinet, 2018.PMID 30019172
- [8]Stojanovic M, et al. What's new in intravenous anaesthesia? Curr Opin Anaesthesiol, 2026.PMID 41677226